求助6篇Springer数据库文献

w2503

1. Clinical Applications of Activated Immune Cells- f# |& X/ f* o4 e) k) `! f/ Y
http://www.springerlink.com/content/p77j27781g92vm53/
$ d: w. z& b0 ]' l' b$ {1 E+ x+ q. V
2. Increased effector–target cell conjugate formation due to HLA restricted specific antigen recognition - ]0 y, k4 h" e6 \$ h
http://www.springerlink.com/content/l667677h47l82363/
6 i4 w' ~$ f8 G* L$ Q
) C! Q9 p% a. x/ ]& R3. Selective Immortalization of Tumor-Specific T Cells to Establish Long-Term T-Cell Lines Maintaining Primary Cell Characteristics
& r! d3 }$ _8 w" Qhttp://www.springerlink.com/content/lg3m7811288qg086/#section=54582&page=16 C; l9 c) _5 K! T3 H: A; C4 f( s
5 I8 @8 m8 H; C' m6 s6 T2 v
4. Extending the Use of Adoptive T Cell Immunotherapy for Infections and Cancer
& X' G+ t; `8 k! e6 o' g; a/ Chttp://www.springerlink.com/content/u67186375261m831/; g! y3 e$ G* j  ]8 M
6 H  ~" F; G% i! Y$ V. v. n
5. Gene Immunotherapy for Non-Small Cell Lung Cancer
& c- }5 a( b9 F7 t/ ^9 g& e+ h& S/ uhttp://www.springerlink.com/content/w2j70l9rx1857154/#section=671351&page=1
7 ]/ B# p3 Z* X3 R
8 b8 ~: V; m7 `  Z( O9 h/ H" D6. Designing TCR for Cancer Immunotherapy0 m0 {, Z: ~/ d4 Z, |# G4 K
http://www.springerlink.com/content/v7607l2v0243k7m7/#section=83660&page=15 L5 {5 {) S6 U; ?* [
5 d/ @" c, K0 W  {0 O
谢谢
4 E+ r) x0 b" U$ ~: C. v. H# y+ f0 u  J* O
: S! {0 e2 _& {5 j$ t1 [8 X
& Y. T; V' |8 R  ?6 d

' g" u+ \: m. n' y' e( U

sunlu36

1 ok

sunlu36

3 ok
9 x5 H4 w; o6 _, L1 j0 o% G6 V& i

sunlu36

4   

sunlu36

5     

sunlu36

6     

w2503

回复 sunlu36 的帖子
/ n: |/ i; B3 o- f  `$ g0 w" g% m* k! Z# ?& {
谢谢

w2503

: m8 R9 i  V3 \0 s" M8 Z! _; a! A$ v/ c; u- S+ C8 V4 O
还差第2篇+ y6 T; k1 x6 a2 `
2. Increased effector–target cell conjugate formation due to HLA restricted specific antigen recognition 9 K) U/ m3 d  E$ r9 t2 n8 ?
http://www.springerlink.com/content/l667677h47l82363/

ceming

2 check the attached file

w2503

回复 ceming 的帖子& V$ y% w0 }& d6 f9 C
6 S$ z% M; h) C* t: w9 ^
谢谢